Chemotherapy‐induced acral erythema in leukemic patients: a report of 15 cases

International Journal of Dermatology - Tập 36 Số 8 - Trang 593-598 - 1997
Zeynep Demirçay1, Oya Gürbüz2, Tülin Budak Alpdoğan2, Deniz Yücelten2, Önder Alpdoǧan2, Özlem Kurtkaya2, Mahmut Bayık2
1Department of Dermatology, Marmara University School of Medicine, Istanbul, Turkey
2From the Departments of Dermatology, Haematology, and Pathology, Marmara University School of Medicine, Istanbul, Turkey

Tóm tắt

Abstract Background Chemotherapy‐induced acral erythema is a distinct localized cutaneous response to certain systemic chemotherapeutic agents. Methods Between January 1990 and December 1994, from a total of 76 leukemic patients who have received combination chemotherapy consisting of cytosine arabinoside and anthracycline antibiotics, 15 patients developed chemotherapy‐induced acral erythema. Fourteen of the patients had acute myelocytic leukemia, and one of them had chronic myelogenous leukemia in blast phase. Clinical features of these 15 patients have been analysed. Biopsy specimens obtained from eight of the patients were also evaluated for histopathologic alterations. Results The overall incidence of this reaction was found to be 19.7% in our group of patients receiving this chemotherapy protocol. The onset of reaction varied from the fourth to the seventeenth days of the chemotherapy and resolved within 2 weeks in most of the patients. Lesions appeared as well‐defined erythema and edema involving the palmar surfaces in all of the patients. In nine of the patients the reaction recurred with subsequent chemotherapies. Scattered necrotic keratinocytes, vacuolar alterations of the basal layer, and mild to moderate perivascular lymphocytic infiltration in the dermis were the histopathologic findings observed in the biopsy specimens. Conclusions Chemotherapy‐induced acral erythema is a frequent reaction in patients who are receiving high‐dose chemotherapy. For patients in whom this self‐limited condition develops, reassurance is the mainstay of therapy. Awareness of this reaction is also important to be able to differentiate it from acute graft versus host disease in patients who receive bone marrow transplants.

Từ khóa


Tài liệu tham khảo

10.7326/0003-4819-97-1-61

Herzig RH, 1983, High‐dose cytosine arabinoside therapy for refractory leukemia, Blood, 62, 361, 10.1182/blood.V62.2.361.361

10.7326/0003-4819-101-6-798

10.7326/0003-4819-103-5-805_1

10.7326/0003-4819-103-2-303_3

10.1097/00000637-198909000-00012

10.1001/archderm.1986.01660210073021

10.1159/000251603

10.7326/0003-4819-98-5-675_2

10.7326/0003-4819-98-5-611

Cox GJ, 1986, Toxic erythema of palms and soles associated with high dose mercaptopurine chemotherapy, Arch Dermatol, 122, 1413, 10.1001/archderm.1986.01660240077020

10.1001/archderm.1995.01690140086015

10.1016/0190-9622(91)70073-B

10.1016/0190-9622(93)70090-G

10.1001/archderm.127.10.1588

10.7326/0003-4819-97-5-783

Thông tin
Thông tin xuất bản

International Journal of Dermatology

Tập 36 Số 8

593-598

Thông tin tác giả